Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
269 Leser
Artikel bewerten:
(1)

Stem Cell Banking Market is expected to generate a revenue of USD 10.31 Billion by 2028, Globally, at 20.17% CAGR: Verified Market Research

The growing applications of biotechnology in healthcare and life sciences, along with this, the growth in the biotechnological expertise has also increased in recent years, allowing biotechnology applications will lead the Stem Cell Banking Market.

JERSEY CITY, N.J., Nov. 7, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Stem Cell Banking Market" By Service (Analysis, Storage, Collection & Transportation, and Processing), By Application (Leukemia, Diabetes, Autism, Cerebral Palsy, Thalassemia, and Others), By Bank Type (Cord Blood and Cord Tissue), By Geographic Scope And Forecast.

Verified Market Research Logo

As per the deep research carried out by Verified Market Research, the global Stem Cell Banking Market size was valued at USD 2.62 Billion in 2020 and is projected to reach USD 10.31 Billion by 2028, growing at a CAGR of 20.17% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=23773

Browse in-depth TOC on "Stem Cell Banking Market"

202 - Pages
126 - Tables
37 - Figures

Global Stem Cell Banking Market Overview

Stem cells are the building blocks of life. These cells are available in the body when the organism is in an embryo state. During the initial stage of life, stem cells divide into the organ cells such as blood cells, brain cells, bone cells, etc. Stem cells have the unique ability to create any organ cells through cell division. During various situations such as injury, aging, or illness, an organ failure is a possible event. This can be easily solved using stem cells stored in stem cell banks. Stem cells can also be used to treat various diseases. The stem cells obtained from the umbilical cord have high regenerative abilities which can cure over 80 different disorders.

During the last 50 years, over 3 million stem cell operations have been performed globally. The applications of stem cells are being widely accepted so much so that the annual number of operations involving stem cells has reached over 50,000. The use of stem cells is not only restrained to the baby but extends to the whole family. With the growing prevalence of non-communicable diseases such as cardiovascular diseases, blood diseases, etc, the demand for stem cell banks is expected to drive the market growth during the forecast period. Technological developments in biotechnology are expected to propel this growth even further.

Key Players

The major players in the market are CBR Systems, Inc., Cordlife, Cryo-Cell, Cryo-Save AG (A Group of Esperite), Lifecell, Stemcyte, Viacord, Smart Cells International Ltd., Cryoviva India, Cordvida.

Verified Market Research has segmented the Global Stem Cell Banking Market On the basis of Service, Application, Bank Type, and Geography.

  • Stem Cell Banking Market, By Service
    • Analysis
    • Storage
    • Collection & Transportation
    • Processing
  • Stem Cell Banking Market, By Application
    • Leukaemia
    • Diabetes
    • Autism
    • Cerebral Palsy
    • Thalassemia
    • Others
  • Stem Cell Banking Market, By Bank Type
    • Cord Blood
    • Cord Tissue
  • Stem Cell Banking Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Stem Cells Market By Product (Induced Pluripotent Stem Cells, Human Embryonic Stem Cells, Adult Stem Cells, and Very Small Embryonic Like Stem Cells), By Therapy (Allogenic and Autologous), By Application (Regenerative Medicine and Drug Discovery and Development), By Geography, And Forecast

Stem Cell Therapy Market By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells), By Therapeutic Application (Musculoskeletal Disorders, Wounds And Injuries), By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Geography, And Forecast

Umbilical Cord Blood (UCB) Stem Cell Market By Product Type (Stem Cell Transplant, Autologous Transplant, Allogenic Transplant), By Distribution Channel (Therapeutics Service Companies, Private and Government Research Institutes), By Geography, And Forecast

Stem Cell Services Market By Product (Customize Service, Stem Cell Differentiation, Assay Development, Screening, Others), By Application (Hospital, Research Institute, Others), By Geography, And Forecast

Top Consumer Healthcare Companies improving consumer lives pole to pole

Visualize Stem Cell Banking Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/stem-cell-banking-market-is-expected-to-generate-a-revenue-of-usd-10-31-billion-by-2028--globally-at-20-17-cagr-verified-market-research-301670270.html

© 2022 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.